View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Daratumumab 1800 / Lenalidomide 25 / Dexamethasone (20/20/40), Multiple Myeloma, Cycle 3-6, First-line
Protocol-ID: 1626 V1.1 (Mini), DRTM1800/LENA25/DEXA(20/20), MM, C3-6, first-lineIndication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
Links
- Daratumumab: Risiko der Reaktivierung von Hepatitis B [BfARM Risikoinf. Rote Hand etc.]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 30.04.2021